Cargando…

Dural MALT lymphoma with disseminated disease

Central nervous system (CNS) lymphoma involving the dura mater is very rare and histologically is usually a subtype of non-Hodgkin's lymphoma (NHL) termed mucosa-associated lymphoid tissue (MALT) lymphoma. We present a case of a 46-year old woman with dural MALT lymphoma that was found to also...

Descripción completa

Detalles Bibliográficos
Autores principales: Matmati, Kelly, Matmati, Nabil, Hannun, Yusuf A., Rumboldt, Zoran, Patel, Sunil, Lazarchick, John, Stuart, Robert, Giglio, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222263/
https://www.ncbi.nlm.nih.gov/pubmed/22184513
http://dx.doi.org/10.4081/hr.2010.e10
_version_ 1782217193390342144
author Matmati, Kelly
Matmati, Nabil
Hannun, Yusuf A.
Rumboldt, Zoran
Patel, Sunil
Lazarchick, John
Stuart, Robert
Giglio, Pierre
author_facet Matmati, Kelly
Matmati, Nabil
Hannun, Yusuf A.
Rumboldt, Zoran
Patel, Sunil
Lazarchick, John
Stuart, Robert
Giglio, Pierre
author_sort Matmati, Kelly
collection PubMed
description Central nervous system (CNS) lymphoma involving the dura mater is very rare and histologically is usually a subtype of non-Hodgkin's lymphoma (NHL) termed mucosa-associated lymphoid tissue (MALT) lymphoma. We present a case of a 46-year old woman with dural MALT lymphoma that was found to also involve a lacrimal gland, inguinal lymph nodes, and bone marrow. Magnetic resonance imaging of the brain showed an extra-axial enhancing mass approximately 6 cm in maximum diameter along the right frontotemporal convexity. Histopathology of the resected dural mass showed MALT lymphoma expressing CD20, CD52, CD19, and CD38. Molecular studies of the B-cell receptor heavy chain demonstrated monoclonality at the involved sites. The patient was treated with four cycles of fludarabine, mitoxantrone, and rituximab with complete remission. She had recurrence in the subcutaneous tissue of the back at 12 months but has remained free of intracranial disease for 31 months. A review of the literature reveals 57 cases of dural MALT lymphoma. Only 4 had extra-CNS involvement at presentation, and only 3 had local recurrence of the dural tumor. Because of the indolent behavior of this tumor, the intracranial portion can be treated conservatively after resection with or without chemotherapy. Deferral of brain radiation can be considered with close clinical and neuroimaging follow up.
format Online
Article
Text
id pubmed-3222263
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher PAGEPress Publications
record_format MEDLINE/PubMed
spelling pubmed-32222632011-12-19 Dural MALT lymphoma with disseminated disease Matmati, Kelly Matmati, Nabil Hannun, Yusuf A. Rumboldt, Zoran Patel, Sunil Lazarchick, John Stuart, Robert Giglio, Pierre Hematol Rep Case Report Central nervous system (CNS) lymphoma involving the dura mater is very rare and histologically is usually a subtype of non-Hodgkin's lymphoma (NHL) termed mucosa-associated lymphoid tissue (MALT) lymphoma. We present a case of a 46-year old woman with dural MALT lymphoma that was found to also involve a lacrimal gland, inguinal lymph nodes, and bone marrow. Magnetic resonance imaging of the brain showed an extra-axial enhancing mass approximately 6 cm in maximum diameter along the right frontotemporal convexity. Histopathology of the resected dural mass showed MALT lymphoma expressing CD20, CD52, CD19, and CD38. Molecular studies of the B-cell receptor heavy chain demonstrated monoclonality at the involved sites. The patient was treated with four cycles of fludarabine, mitoxantrone, and rituximab with complete remission. She had recurrence in the subcutaneous tissue of the back at 12 months but has remained free of intracranial disease for 31 months. A review of the literature reveals 57 cases of dural MALT lymphoma. Only 4 had extra-CNS involvement at presentation, and only 3 had local recurrence of the dural tumor. Because of the indolent behavior of this tumor, the intracranial portion can be treated conservatively after resection with or without chemotherapy. Deferral of brain radiation can be considered with close clinical and neuroimaging follow up. PAGEPress Publications 2010-12-03 /pmc/articles/PMC3222263/ /pubmed/22184513 http://dx.doi.org/10.4081/hr.2010.e10 Text en ©Copyright K. Matmati et al., 2010 This work is licensed under a Creative Commons Attribution 3.0 License (by-nc 3.0). Licensee PAGEPress, Italy
spellingShingle Case Report
Matmati, Kelly
Matmati, Nabil
Hannun, Yusuf A.
Rumboldt, Zoran
Patel, Sunil
Lazarchick, John
Stuart, Robert
Giglio, Pierre
Dural MALT lymphoma with disseminated disease
title Dural MALT lymphoma with disseminated disease
title_full Dural MALT lymphoma with disseminated disease
title_fullStr Dural MALT lymphoma with disseminated disease
title_full_unstemmed Dural MALT lymphoma with disseminated disease
title_short Dural MALT lymphoma with disseminated disease
title_sort dural malt lymphoma with disseminated disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222263/
https://www.ncbi.nlm.nih.gov/pubmed/22184513
http://dx.doi.org/10.4081/hr.2010.e10
work_keys_str_mv AT matmatikelly duralmaltlymphomawithdisseminateddisease
AT matmatinabil duralmaltlymphomawithdisseminateddisease
AT hannunyusufa duralmaltlymphomawithdisseminateddisease
AT rumboldtzoran duralmaltlymphomawithdisseminateddisease
AT patelsunil duralmaltlymphomawithdisseminateddisease
AT lazarchickjohn duralmaltlymphomawithdisseminateddisease
AT stuartrobert duralmaltlymphomawithdisseminateddisease
AT gigliopierre duralmaltlymphomawithdisseminateddisease